HopeStage
Back to all studies
CompletedNCT03235154

Epclusa for Hepatitis C in an Outpatient Addiction Clinic

About this titleRead the official source — NCT03235154
Medication studyAges 18+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
SomervilleSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 11, 2017
Recruitment status
Completed
Enrollment listed in the registry
11
Sponsor
Community Research Initiative of New England
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT03235154
Official title
Show the full official title

Bridging Care to HCV Treatment Among Opiate Dependent Patients on Buprenorphine/Naloxone Maintenance Therapy: A Pilot Study of Treating HCV With Epclusa at a Psychiatrist-staffed Outpatient Addiction Clinic

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Somerville

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Community Research Initiative of New England.

Did this study involve medication?

Yes. The study involved medication, including sofosbuvir/velpatasvir.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies